engleski

Short‐term outcomes of patients with chronic liver disease hospitalised with COVID‐19

Background and aims: Patients with chronic liver disease (CLD) might have aggravated course upon acquisition of coronavirus disease 2019 (COVID- 19). We aimed to analyse the outcomes of patients with CLD who were hospitalized due to COVID-19. Methods: Medical records of 4014 patients hospitalized due to COVID-19 in a regional referral hospital over a 12- month period were analysed. Patients with CLD were identified based on discharge diagnoses according to ICD-10 classification. Patients were followed for 30 days from admission, and their outcomes (intensive care unit (ICU) admission, mechanical ventilation (MV) or death) were analysed. Results: Of the 4014 patients, 110 (2.7%) had CLD and 49 (1.2%) had cirrhosis. Median age of CLD patients was 67.5 years, 79 (71.8%) were males, 224 (23.5%) obese, 56 (50.9%) reported alcohol abuse, 24 (21.8%) had non-alcoholic fatty liver disease, 11 (10%) viral hepatitis and 98 (89.1%) had pneumonia. Median length of hospitalization was 12 days, 32 (29.1%) patients required ICU admission and 23 (20.9%) MV, while 43 (39.1%) died. In univariate analysis, patients with cirrhosis (45% vs 73%, HR=2.95 ; P<0.001), but not those with non-cirrhotic CLD (74% vs 73%, P>0.05), experienced worse 30-days survival when compared to age, sex and COVID-19 duration matched cohorts. In a logistic regression analysis conducted on the overall and matched cohorts, liver cirrhosis, but not CLD, predicted inferior survival independently of age, comorbidities and severity of COVID-19, with a fourfold higher adjusted risk of 30-day mortality. Conclusion: Cirrhosis is independently associated with higher 30-day mortality of hospitalized patients with COVID-19.

COVID-19 ; chronic liver disease ; liver cirrhosis ; prognosis ; mortality

nije evidentirano